In the original article, the Reference for “Blazquez, C. et al. (2006)” was incorrectly written as “Naeem et al. (2006).” The correct and full citation is “Blázquez, C., Carracedo, A., Barrado, L., Real, P. J., Fernández-Luna, J. L., Velasco, G., Malumbres, M., Guzmán, M. (2006). Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J. 20, 2633–2635. 10.1096/fj.06-6638fje.”
In the original article, the Reference for “Velasco, G., (2016)” was incorrectly written as “Fujimura et al. (1989).” The correct and full citation is “Velasco, G., Hernandez-Tiedra, S., Davila, D., and Lorente, M. (2016). The use of cannabinoids as anticancer agents. Prog. Neuropsychopharmacol. Biol. Psychiarty. 64, 259-266. 10.1016/j.pnpbp 2015.05.010.”
In the original article, the Reference for “Salazar (2009)” was incorrectly written as “Jenkins, M.A., et al. (2006).” The correct and full citation is “Salazar, M., Carracedo, A., Salanueva, I. J., Hernandez-Tiedra, S., Lorente, M., Egia, A., Vazquez, P., Blazquez, C., Torres, S., Garcia, S., Nowak, J., Fimai, G. M., Piacentini, M., Cecconi, F., Pandolfi, P. P., Gonzalez-Feria, L., Iovanna, J. L., Guzman, M., Boya, P., and Velasco, G. (2009). Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119, 1359-1372. 10.1172/JCI37948.”
In the original article, the Reference for “McKallip (2005)” was incorrectly written as “Martin-Banderas et al. (2015).” The correct and full citation is “McKallip, R. J., Nagarkatti, M., and Nagarkatti, P. S. (2005). Delta-9- tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J. Immunol 174, 3281-3289. 10.4049/jimmunol.174.6.3281.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
cannabinoids, cancer, in vivo, clinical studies, clinical trials, therapeutics, cancer models, endocannabinoids
Citation
Ladin DA, Soliman E, Griffin L and Van Dross R (2021) Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents. Front. Pharmacol. 12:732903. doi: 10.3389/fphar.2021.732903
Received
29 June 2021
Accepted
30 June 2021
Published
16 July 2021
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2021
Updates
Copyright
© 2021 Ladin, Soliman, Griffin and Van Dross.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rukiyah Van Dross, vandrossr@ecu.edu
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.